Cargando…

Quality of Life, Toxicity and Unmet Needs in Nasopharyngeal Cancer Survivors

Concerted research efforts over the last three decades have resulted in improved survival and outcomes for patients diagnosed with nasopharyngeal carcinoma (NPC). The evolution of radiotherapy techniques has facilitated improved dose delivery to target volumes while reducing dose to the surrounding...

Descripción completa

Detalles Bibliográficos
Autores principales: McDowell, Lachlan, Corry, June, Ringash, Jolie, Rischin, Danny
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303258/
https://www.ncbi.nlm.nih.gov/pubmed/32596155
http://dx.doi.org/10.3389/fonc.2020.00930
_version_ 1783548014376255488
author McDowell, Lachlan
Corry, June
Ringash, Jolie
Rischin, Danny
author_facet McDowell, Lachlan
Corry, June
Ringash, Jolie
Rischin, Danny
author_sort McDowell, Lachlan
collection PubMed
description Concerted research efforts over the last three decades have resulted in improved survival and outcomes for patients diagnosed with nasopharyngeal carcinoma (NPC). The evolution of radiotherapy techniques has facilitated improved dose delivery to target volumes while reducing dose to the surrounding normal tissue, improving both disease control and quality of life (QoL). In parallel, clinical trials focusing on determining the optimal systemic therapy to use in conjunction with radiotherapy have been largely successful, resulting in improved locoregional, and distant control. As a consequence, neoadjuvant chemotherapy (NACT) prior to definitive chemoradiotherapy has recently emerged as the preferred standard for patients with locally advanced NPC. Two of the major challenges in interpreting toxicity and QoL data from the published literature have been the reliance on: (1) clinician rather than patient reported outcomes; and (2) reporting statistical rather than clinical meaningful differences in measures. Despite the lower rates of toxicity that have been achieved with highly conformal radiotherapy techniques, survivors remain at moderate risk of persistent and long-lasting treatment effects, and the development of late radiation toxicities such as hearing loss, cranial neuropathies and cognitive impairment many years after successful treatment can herald a significant decline in QoL. Future approaches to reduce long-term toxicity will rely on: (1) identifying individual patients most likely to benefit from NACT; (2) development of response-adapted radiation strategies following NACT; and (3) anticipated further dose reductions to organs at risk with proton and particle therapy. With increasing numbers of survivors, many in the prime of their adult life, research to identify, and strategies to address the unmet needs of NPC survivors are required. This contemporary review will summarize our current knowledge of long-term toxicity, QoL and unmet needs of this survivorship group.
format Online
Article
Text
id pubmed-7303258
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-73032582020-06-26 Quality of Life, Toxicity and Unmet Needs in Nasopharyngeal Cancer Survivors McDowell, Lachlan Corry, June Ringash, Jolie Rischin, Danny Front Oncol Oncology Concerted research efforts over the last three decades have resulted in improved survival and outcomes for patients diagnosed with nasopharyngeal carcinoma (NPC). The evolution of radiotherapy techniques has facilitated improved dose delivery to target volumes while reducing dose to the surrounding normal tissue, improving both disease control and quality of life (QoL). In parallel, clinical trials focusing on determining the optimal systemic therapy to use in conjunction with radiotherapy have been largely successful, resulting in improved locoregional, and distant control. As a consequence, neoadjuvant chemotherapy (NACT) prior to definitive chemoradiotherapy has recently emerged as the preferred standard for patients with locally advanced NPC. Two of the major challenges in interpreting toxicity and QoL data from the published literature have been the reliance on: (1) clinician rather than patient reported outcomes; and (2) reporting statistical rather than clinical meaningful differences in measures. Despite the lower rates of toxicity that have been achieved with highly conformal radiotherapy techniques, survivors remain at moderate risk of persistent and long-lasting treatment effects, and the development of late radiation toxicities such as hearing loss, cranial neuropathies and cognitive impairment many years after successful treatment can herald a significant decline in QoL. Future approaches to reduce long-term toxicity will rely on: (1) identifying individual patients most likely to benefit from NACT; (2) development of response-adapted radiation strategies following NACT; and (3) anticipated further dose reductions to organs at risk with proton and particle therapy. With increasing numbers of survivors, many in the prime of their adult life, research to identify, and strategies to address the unmet needs of NPC survivors are required. This contemporary review will summarize our current knowledge of long-term toxicity, QoL and unmet needs of this survivorship group. Frontiers Media S.A. 2020-06-12 /pmc/articles/PMC7303258/ /pubmed/32596155 http://dx.doi.org/10.3389/fonc.2020.00930 Text en Copyright © 2020 McDowell, Corry, Ringash and Rischin. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
McDowell, Lachlan
Corry, June
Ringash, Jolie
Rischin, Danny
Quality of Life, Toxicity and Unmet Needs in Nasopharyngeal Cancer Survivors
title Quality of Life, Toxicity and Unmet Needs in Nasopharyngeal Cancer Survivors
title_full Quality of Life, Toxicity and Unmet Needs in Nasopharyngeal Cancer Survivors
title_fullStr Quality of Life, Toxicity and Unmet Needs in Nasopharyngeal Cancer Survivors
title_full_unstemmed Quality of Life, Toxicity and Unmet Needs in Nasopharyngeal Cancer Survivors
title_short Quality of Life, Toxicity and Unmet Needs in Nasopharyngeal Cancer Survivors
title_sort quality of life, toxicity and unmet needs in nasopharyngeal cancer survivors
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303258/
https://www.ncbi.nlm.nih.gov/pubmed/32596155
http://dx.doi.org/10.3389/fonc.2020.00930
work_keys_str_mv AT mcdowelllachlan qualityoflifetoxicityandunmetneedsinnasopharyngealcancersurvivors
AT corryjune qualityoflifetoxicityandunmetneedsinnasopharyngealcancersurvivors
AT ringashjolie qualityoflifetoxicityandunmetneedsinnasopharyngealcancersurvivors
AT rischindanny qualityoflifetoxicityandunmetneedsinnasopharyngealcancersurvivors